Contingency Management Innovations
CMI, a division of Q2i, is the industry-leading developer and supplier of technology to design, implement and securely manage contingency management (CM) programs.
About CMI
Contingency Management (CM) is a reward-based intervention grounded in the principles of operant conditioning, designed to drive behavior change and reinforce positive actions. It provides tangible, often monetary, rewards tied directly to achieving specific goals or behaviors.
Traditional CM programs often face challenges, including the need for intensive management, administration, and oversight to maintain program fidelity. These programs typically require highly trained staff to manage operations and additional personnel for backend tasks such as purchasing rewards and maintaining accounting records. Moreover, traditional CM systems lack flexibility, making modifications and updates slow and costly.
CMI’s patent-pending technology addresses these challenges by digitizing and automating traditional CM processes. This innovative solution calculates, delivers, and tracks incentives in real time, ensuring program fidelity while streamlining operations. By reducing costs and simplifying administration, CMI enhances the experience for both staff and participants, ultimately improving program outcomes.
Research has consistently demonstrated the effectiveness of CM in enhancing treatment outcomes across various populations, treatment modalities, and settings.
CMI’s platforms represent a groundbreaking advancement in technology-enabled CM, setting the market standard.
Every day, more healthcare organizations and patients trust CMI technology to manage their contingency management programs than all our competitors combined.
Mission
Vision
Our vision is to drive innovation that simplifies the implementation and management of Contingency Management (CM) programs by reducing administrative burdens and other challenges. We are committed to championing evidence-based designs that deliver optimal success, with security and maximum fidelity at the forefront.
Solutions
Janus
Janus technology is the market-leading incentive management platform used by healthcare organizations to design, configure, implement, and manage their CM programs securely, effectively, and efficiently.
CMI’s patent-pending Janus technology consists of a CM engine that can be configured to manage various budgets, reinforcement periods, any array of targeted events and behaviors with configurable reset ladders.
Janus offers a clinician dashboard and has open APIs for easy connection to EHRs and/or other third-party systems. Janus also includes a mobile application providing instant in-app delivery of rewards.
CMI’s Janus technology is named after the god of beginnings and ends in Roman mythology. Janus frequently symbolized change and transitions such as the progress of the past to the future. The Romans named the month of January in his honor.
SIMS
State Incentive Management System (SIMS) is a platform used by Departments of Health to manage their contingency management programs.
For the Department of Health (State, County, City, etc.):
SIMS enables the easy and secure management of a CM program, configured to exact incentive protocols and reinforcement designs, and ensures maximum fidelity of the program across multi-sites. SIMS provides proactive security features and comprehensive reporting with real-time analytics on all key performance indicators of the program.
For providers:
SIMS provides the healthcare organization in the Department of Health program with a solution that is quick to implement and easy for the site team to use. Visibility of their patients if available for local engagement and management.
For Patients/beneficiaries:
SIMS provides beneficiaries with an engaging real-time experience that optimizes their probability of success; this can be with or without a mobile app component.
NALCAM
NALCAM is an app that helps save lives! It trains individuals on how to use naloxone, then encourages them with daily incentives for a duration of time to carry this lifesaving medication with them. This helps individuals create a habit of carrying naloxone every day.
40% of opioid overdoses are witnessed or discovered in time for Naloxone to be effective. However, researchers found only a 9% naloxone carriage rate in a group of people who inject drugs. The World Health Organization aims to achieve a 90% naloxone carriage rate for those trained and given naloxone. NALCAM helps organizations and communities achieve their target carriage rates.
IMP
Incentive Manager Plug-in (IMP) enables organizations to quickly, cost-effectively, and securely add a contingency management component to their applications. API’s can be exposed to endpoints, making features of the incentive manager available for consumption by authorized external services. These include calculating and immediately delivering rewards according to the desired reinforcement schedule, including escalation and reset ladders.
The plug-in manages various validation methods regarding accomplishing targeted behaviors. Incentives are delivered in real time and through a selection of delivery modalities.
IMP provides inbuilt sophisticated security tools that proactively control fraud, waste, and abuse and offers a comprehensive reporting suite. IMP also provides a patent-pending contextual agent (AI-powered) to coach individuals around all aspects and interactions of their CM program.
CMI’s technology was developed in conjunction with academic partners that include:
100% Cloud, Ready-to-Go
Start using CMI to support
your program in minutes.
Modern User Interface
The CMI dashboard and app interface is intuitive and easy to navigate for an unequalled user experience.
Turnkey Design
Designed by academic and industry professionals to be plug and play.
Flexible and Scalable
CMI can be used as a stand-alone program management solution or easily integrated with third-party systems.
Safe and Secure
Built and deployed on AWS GovCloud to meet government compliance mandates for hosting sensitive data.
Research
Here is a compendium of CM studies, clinical trials, and evidence base.
ADHD
Alzheimers
Anorexia and Bulimia
AUD
Childhood Huntington's
Childhood Phobic Disorders
Depression
Diabetes
Gaming Disorder
Hyperlipidemia
Hypertension
Hoarding Disorder
Marijuana Dependence
Methamphetamine Dependence
Obesity/weight loss
Orofacial Dysfunction
OUD
Prenatal Smoking Cessation
Psychogenic Vomiting
Tobacco Use Disorder
HIV/Aids
Schizophrenia, Bipolar, and Anosognosia
Smartphone and Social Media Use
StimUD
